false
OasisLMS
Catalog
Advanced Pharmacotherapy in Critical Care Online
Multimodal Approach to Vasopressors (Patrick M. Wi ...
Multimodal Approach to Vasopressors (Patrick M. Wieruszewski, PharmD, BCCCP)
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Pharmacist Patrick Wieroszewski discusses a multimodal approach to vasopressors in patients with vasodilatory shock. Vasodilatory shock can result from various causes like sepsis, postoperative vasoplegia, and anaphylaxis, leading to decreased perfusing pressures and inadequate oxygen delivery. Traditional stepwise escalation of vasopressors may lead to prolonged hypoperfusion and multiple organ failure. The Surviving Sepsis Campaign recommends using norepinephrine as a first-line agent, with vasopressin and epinephrine as additional options. Studies show that some patients may not respond to vasopressors, highlighting the need for personalized vasopressor approaches. The use of vasopressors like vasopressin and angiotensin II, along with norepinephrine, can improve hemodynamic responsiveness and outcomes in shock patients. Implementing Joint Commission standards for titratable medications and utilizing smart pumps can enhance the safety and effectiveness of vasopressor therapies. An integrated approach to vasopressor therapy, focusing on rapid restoration of organ perfusion and personalized patient care, is essential in managing shock effectively.
Keywords
vasopressors
vasodilatory shock
sepsis
norepinephrine
vasopressin
epinephrine
organ perfusion
personalized care
smart pumps
×
Please select your language
1
English